After announcing the tie-up almost a year ago, India's Dr. Reddy's Laboratories ($RDY) finally expects to ink a joint...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
DRUG MARKETING
Pharmaceutical companies are bombarding the airwaves with TV ads, showering doctors with gifts to get them to prescribe more of their drugs, and practicing other marketing tactics that can get them into hot water. The topic of drug marketing will examine the myriad ways the industry pushes its products -- and the inevitable controversies that result.
Drug Marketing is part of Business Exchange, suggested by
Arlene Weintraub.
This topic contains
443 news
and
305 blog
items.
Read updated news, blogs, and resources about Drug Marketing. Find user-submitted articles and reactions on Drug Marketing from
like-minded professionals.
Blogs
Recent blog posts on this topic.
We sound like a broken record when it comes to Valeant Pharmaceuticals ($VRX): The Canadian drugmaker has made yet...
India and China are on most expansion-minded drugmakers' shopping lists. So, it's not a huge surprise that top Japanese...
India's Dr. Reddy's Laboratories plans to go shopping in Russia. The generics specialist wants to expand its portfolio...
There is certainly nothing surprising that Pfizer or any other large drugmaker is planning to cut jobs.
Johnson & Johnson's ($JNJ) legion of legal problems is one less strong. The company agreed to pay $85 million and...
Top of the morning to you. We have just returned from one of the local schoolhouses, where we have deposited a sleepy...
South Africa's Aspen Pharmacare has posted some strong full-year sales and profits growth, thanks in part to expansion...
Is this surprising? A new study finds that 39 percent of the public mistakenly believes that the FDA approves only...
Three Democratic members of the US House are pressing the US Federal Trade Commission to conduct an in-depth analysis...
Johnson & Johnson ($JNJ) CEO Bill Weldon (photo) is the highest-paid Big Pharma chief, no question. His $28.
Biogen Idec ($BIIB) is taking its multiple sclerosis marketing in house. The Massachusetts-based company has bought out...
Emerging markets continue to beckon Big Pharma. Eli Lilly ($LLY) is in partnership talks with Turkey's Mustafa Nevzat...
Once again, a web page is deemed problematic by the FDA. In a letter sent by the agency earlier this week, Pfizer was...
The Federal Trade Commission has found a new target in its quest to foster competition in the drug market: authorized...
Piramal's generics excitement in India was only the first step in becoming a "major player" in global pharma.
It's no secret drugmakers have been hiring sales reps by the dozen in emerging markets. As sales in mature markets...
Takeda may well be eyeing a buyout to expand in India, but Cipla, one of its supposed targets, has its own emerging...
Remember how side effects of a prescription med were read so quickly in television ads that it was impossible to...
AstraZeneca CEO David Brennan (photo) announced at a conference in Istanbul that his company will no longer foot the...
GlaxoSmithKline CEO Andrew Witty (photo) says the company's emerging-markets strategy is working. In an interview with...
Hello, everyone, and welcome to the working week. Another overcast day is unfolding here on the Pharmalot corproate...
Word on the street proved true today; Takeda Pharmaceutical announced it had agreed to buy Nycomed for almost $14...
What's better than Big Pharma marketing power? Big Pharma marketing power times two. Merck has tapped Roche to help...
New projections for global drug sales look pretty for generics makers--but not so pretty for brands. The growth in...
Top Sources: Drug Marketing
- News
- medicinesocialjustice.blogspot.com
- blogs.nature.com
- carlatpsychiatry.blogspot.com
- doseofdigital.com
- drugreptoys.blogspot.com
- cfpie.com
- Pharmalot
- CNBC
- eyeonfda.com
account